Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Mesirow Financial Investment Management Inc.

Mesirow Financial Investment Management Inc. lessened its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 49.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 40,230 shares of the pharmacy operator’s stock after selling 38,878 shares during the period. Mesirow Financial Investment Management Inc.’s holdings in Walgreens Boots Alliance were worth $375,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of WBA. First Financial Corp IN increased its stake in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 885 shares during the period. Golden State Wealth Management LLC acquired a new position in Walgreens Boots Alliance during the 4th quarter valued at about $26,000. Riverview Trust Co increased its stake in Walgreens Boots Alliance by 123.8% during the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after buying an additional 1,590 shares during the period. Venturi Wealth Management LLC acquired a new position in Walgreens Boots Alliance during the 4th quarter valued at about $28,000. Finally, TD Private Client Wealth LLC increased its stake in Walgreens Boots Alliance by 8,670.3% during the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after buying an additional 3,208 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $11.39 on Friday. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $22.05. The company has a 50-day moving average of $10.64 and a two-hundred day moving average of $9.72. The stock has a market cap of $9.84 billion, a price-to-earnings ratio of -1.11, a PEG ratio of 1.31 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. During the same period last year, the company posted $0.66 earnings per share. The business’s revenue for the quarter was up 7.6% on a year-over-year basis. On average, equities research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have commented on WBA shares. Bank of America raised their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Royal Bank of Canada raised their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Evercore ISI raised their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. Truist Financial reduced their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Finally, Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $11.54.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.